In addition, TAZ activation could drive non-CSCs into cells with tumor initiating and self-renewal potential [52], and loss of TAZ impairs the invasiveness, self-renewal, and tumorigenic capacity [220]. The gene discussed is WWTR1; the disease is neoplasm.